Bone Marrow Transplant Clinical Trial
Official title:
Spanish BMT4me Usability & Acceptability
Verified date | April 2024 |
Source | Nationwide Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | May 1, 2026 |
Est. primary completion date | May 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 0 Years to 17 Years |
Eligibility | Inclusion Criteria: Eligible caregivers must have children who: 1. Are 0-17 years old 2. Underwent HCT 3. Are planned for discharge prior to day 100 post-transplant Primary caregivers must: 1. Be Spanish speaking 2. Be =18 years old 3. Have a smartphone (iOS or Android) capable of downloading apps Exclusion Criteria: (a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study. |
Country | Name | City | State |
---|---|---|---|
United States | Nationwide Children's Hospital | Columbus | Ohio |
United States | Columbia University Irving Medical Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Nationwide Children's Hospital | Columbia University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assess app usability using the System Usability Scale (SUS) | Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form. he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps. The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability. A score of > 68 is considered above average. | 6/1/24 - 5/1/26 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02451462 -
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients
|
N/A | |
Completed |
NCT03654599 -
Effects of Digital Stories Intervention on Psychosocial Well-being
|
N/A | |
Active, not recruiting |
NCT04395222 -
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
|
Phase 2 | |
Not yet recruiting |
NCT05603156 -
A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
|
N/A | |
Completed |
NCT03530969 -
Geriatric Communication Skills Training Program for Oncology Clinicians
|
N/A | |
Recruiting |
NCT04115241 -
Activity Levels in Bone Marrow Transplant Patients
|
||
Completed |
NCT00143780 -
Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
|
Phase 4 | |
Completed |
NCT05662631 -
Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients
|
N/A | |
Completed |
NCT03028961 -
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT02575079 -
Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT
|
N/A | |
Active, not recruiting |
NCT02665065 -
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
|
Phase 3 | |
Completed |
NCT01735565 -
Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT04041219 -
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
|
Phase 4 | |
Completed |
NCT03030248 -
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
|
Phase 2 | |
Completed |
NCT00695123 -
Screening for Subjects to Participate in Studies of Blood Disorders
|
||
Terminated |
NCT02057289 -
A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
|
Phase 1 | |
Completed |
NCT04275830 -
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
|
N/A | |
Completed |
NCT03902210 -
BMT Online Wellness Study
|
N/A | |
Completed |
NCT03245788 -
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
|
N/A | |
Completed |
NCT03758911 -
Perspectives on Bone Marrow Donors Who Donate for Their Parent
|